Prenetics Global Limited Class A Ordinary Share (PRE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | PRE | AMGN | BMY | GILD | VRTX |
| Company | Prenetics Global Limited Class A Ordinary Share | Amgen Inc | Bristol-Myers Squibb Company | Gilead Sciences Inc | Vertex Pharmaceutic |
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NYSE | NASDAQ | NASDAQ |
| Open | 5.70 | 259.05 | 56.31 | 90.75 | 401.31 |
| High | 5.90 | 261.19 | 57.03 | 91.53 | 404.74 |
| Low | 5.63 | 257.14 | 55.94 | 90.33 | 399.00 |
| Last | 5.63 | 257.62 | 56.63 | 91.08 | 401.97 |
| Change | -0.02 | -3.60 | +0.06 | -0.33 | -5.14 |
| % Change | -0.30% | -1.38% | +0.11% | -0.36% | -1.26% |
| Volume | 6,006 | 2,222,030 | 5,803,341 | 3,942,087 | 1,116,803 |
| 20-Day Average Volume | 10,000 | 3,646,642 | 11,142,260 | 6,113,536 | 1,871,016 |
| Previous Close | 5.65 | 261.22 | 56.57 | 91.41 | 407.11 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | No | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 5.58 | 265.59 | 57.13 | 92.27 | 431.46 |
| 20-Day Raw Stochastic | 67.02% | 14.89% | 33.47% | 33.91% | 23.65% |
| 20-Day Relative Strength | 58.06% | 31.45% | 49.47% | 48.92% | 34.47% |
| Weighted Alpha | +4.22 | -20.77 | +18.40 | +14.90 | -13.55 |
| Today's Opinion | 56% Buy | 88% Sell | 56% Buy | 64% Buy | 88% Sell |
| Previous Opinion | 56% Buy | 88% Sell | 56% Buy | 72% Buy | 72% Sell |
| Last Month's Opinion | 96% Sell | 72% Sell | 100% Buy | 88% Buy | 8% Sell |
| Performance | |||||
| 5-Days | |||||
| %Chg | -1.29% since 12/27/24 | -2.05% since 12/27/24 | -1.84% since 12/27/24 | -3.29% since 12/27/24 | -1.86% since 12/27/24 |
| Low | 5.61 on 01/03/25 | 257.27 on 01/06/25 | 55.93 on 12/31/24 | 90.32 on 01/06/25 | 399.00 on 01/06/25 |
| High | 5.93 on 12/30/24 | 263.58 on 01/02/25 | 57.60 on 12/30/24 | 94.00 on 12/30/24 | 411.65 on 01/03/25 |
| 1-Month | |||||
| %Chg | +9.21% since 12/06/24 | -5.61% since 12/06/24 | -4.65% since 12/06/24 | -1.21% since 12/06/24 | -13.19% since 12/06/24 |
| Low | 5.00 on 12/13/24 | 253.30 on 12/19/24 | 55.04 on 12/13/24 | 89.15 on 12/13/24 | 377.85 on 12/19/24 |
| High | 5.94 on 12/26/24 | 280.00 on 12/09/24 | 59.76 on 12/09/24 | 94.65 on 12/11/24 | 476.46 on 12/10/24 |
| 3-Month | |||||
| %Chg | +13.97% since 10/04/24 | -19.52% since 10/04/24 | +4.93% since 10/04/24 | +7.60% since 10/04/24 | -11.89% since 10/04/24 |
| Low | 3.87 on 10/09/24 | 253.30 on 12/19/24 | 51.31 on 10/15/24 | 84.17 on 10/11/24 | 377.85 on 12/19/24 |
| High | 5.94 on 12/26/24 | 329.17 on 10/11/24 | 61.08 on 11/11/24 | 98.90 on 11/11/24 | 519.88 on 11/08/24 |
| 6-Month | |||||
| %Chg | -5.85% since 07/05/24 | -17.24% since 07/05/24 | +42.76% since 07/05/24 | +36.47% since 07/05/24 | -15.47% since 07/05/24 |
| Low | 3.72 on 09/25/24 | 253.30 on 12/19/24 | 39.50 on 07/08/24 | 66.34 on 07/09/24 | 377.85 on 12/19/24 |
| High | 6.99 on 07/12/24 | 346.85 on 07/25/24 | 61.08 on 11/11/24 | 98.90 on 11/11/24 | 519.88 on 11/08/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 51,594 | 140,414,384 | 114,733,968 | 113,921,184 | 104,842,624 |
| Shares Outstanding, K | 9,137 | 537,533 | 2,028,177 | 1,246,266 | 257,529 |
| Annual Sales | 21,740,000 | 28,190,000,000 | 45,006,000,000 | 27,116,000,000 | 9,869,200,000 |
| Annual Net Income | -62,720,000 | 6,717,000,000 | 8,025,000,000 | 5,665,000,000 | 3,619,600,000 |
| Last Quarter Sales | 7,780,000 | 8,503,000,000 | 11,892,000,000 | 7,545,000,000 | 2,771,900,000 |
| Last Quarter Net Income | -10,670,000 | 2,830,000,000 | 1,211,000,000 | 1,253,000,000 | 1,045,400,000 |
| 60-Month Beta | -0.30 | 0.56 | 0.45 | 0.18 | 0.40 |
| Per-Share Information | |||||
| Most Recent Earnings | -0.84 on 11/27/24 | 5.58 on 10/30/24 | 1.80 on 10/31/24 | 2.02 on 11/06/24 | 4.38 on 11/04/24 |
| Latest Earnings Date | 11/25/24 | 02/04/25 | 02/06/25 | 02/11/25 | 02/03/25 |
| Most Recent Dividend | N/A | 2.250 on 11/18/24 | 0.620 on 01/03/25 | 0.770 on 12/13/24 | N/A |
| Next Ex-Dividends Date | 02/17/16 | 02/14/25 | 01/03/25 | 12/13/24 | N/A |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 13.49 | 48.54 | 20.74 | 0.00 |